UBS to present Beyond Pop: Art of the Everyday at Art Basel Miami Beach 2025, featuring new commission by Katherine Bernhardt Katherine Bernhardt’s new commission in the UBS Lounge to debut alongside ...
FOX News Media will present the 6th annual "All American Christmas Tree Lighting" on Friday during a special episode of "The Five." "The Five" co-hosts Greg Gutfeld, Dana Perino, Jessica Tarlov, Jesse ...
ARS Pharma to showcase a late-breaking oral presentation and six poster presentations highlighting real world impact of neffy® (epinephrine nasal spray) Oral presentation to report results from real ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that it will showcase 46 abstracts, including 12 oral presentations, ...
Art, in all its forms, serves as an archive. I was reminded of that during a just-opened exhibit in Detroit’s Carr Center, Bridges, Because of Them, which honors the city’s artistic past while ...
General Mills, Inc. stock has suffered yet another significant decline, losing nearly a third of its value over the past 12 months. Although now is not the time to sell, there are some important ...
Ayodhya (UP), October 19, 2025 (ANI): Uttar Pradesh’s holy city Ayodhya was brilliantly illuminated with vibrant firecrackers as the much-awaited Deepotsav2025 celebrations took center stage.
DUBLIN and CHICAGO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a company focused on delivering next generation oral and IV antibiotics to treat infections ...
Just about every laptop, desktop, and smartphone in your life can tell you the date, time, and current weather predictions. However, sometimes it’s nice to have simple data displayed on a bespoke ...
Republican New Jersey gubernatorial hopeful Jack Ciattarelli is running neck and neck against Rep. Mikie Sherrill in the high-stakes race — after making rapid gains in polling over recent weeks, ...
LONDON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Spur Therapeutics today announced it will present new clinical data for avigbagene parvec (FLT201), its Phase 3-ready gene therapy candidate for Gaucher ...